NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Research to Prevent Blindness

Research to Prevent Blindness

New York City, New Yorkrpbusa.org

Overview

Research to Prevent Blindness is a non-profit organization that supports eye research directed at the prevention, treatment, or eradication of all diseases that threaten vision by providing grants to scientists and medical institutions.

Year Founded

1960

Portfolio Companies

2

Website

rpbusa.org

Investments

Research to Prevent Blindness investments
CompanyDateStageLead
AsclepiX TherapeuticsNov 2018GrantCo-investor
Selagine, Inc.-GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year Founded1960

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.